GSTM1 and colorectal cancer: The use of faecal immunochemical testing (FIT) for haemoglobin (Hb) in the diagnostic pathway for symptomatic patients suspected to have colorectal cancer has been rapidly adopted over the past 5 years, accelerated by the endoscopy restrictions imposed during the coronavirus-19 pandemic5.